Joint IP Committee definition

Joint IP Committee or “JIPC” is defined in Section 4.3.1.

Joint IP Committee shall have the meaning set forth in Article 11.4(a).

Joint IP Committee has the meaning set forth in Section 4.2(c) (Joint IP Committee);

Examples of Joint IP Committee in a sentence

• Promptly after the Effective Date, the JSC shall establish a Joint IP Committee (“JIPC”).

• Each Party may appoint substitutes or alternates for its Joint IP Committee members at any time by written notice the other Party.

• The Joint IP Committee shall appoint a Lead IP Party for each Program Invention which is part of the Collaboration IP, taking into consideration the capabilities of each Party’s IP department and each Party’s specific expertise with respect to the relevant Program Invention.

• In case of a dispute, the matter shall be referred to the Joint IP Committee, which in turn shall refer any unresolved matter to the Joint Steering Committee.

• Each Party shall have the right to defend itself against the Infringement Attack in accordance with the decisions and instructions of the Joint IP Committee.

• Any such result could cause investors to lose confidence in the Company’s reported financial information, which could have a material adverse effect on the trading price of the Company’s Common Shares.

• The Parties may mutually agree to change the size of the Joint IP Committee at any time.

• If the alleged infringement relates to a Collaboration Product and is not subject to an indemnification pursuant to Section 13.2a, all reasonable costs associated with the defense of the Infringement Attack and approved by the Joint IP Committee, including any payment due to such Third Party as damages or in settlement allocated to sales of the Collaboration Product, will be shared equally (50:50) between the Parties as part of the Shared Costs.

• Unless otherwise agreed by the Joint IP Committee, any patent application disclosing, covering or claiming Collaboration IP shall not be filed until the respective Clinical Candidate has been selected as a Collaboration Product.

• The minutes shall be considered as approved by the members of the Joint IP Committee, unless the chairman has received objections and/or comments to the minutes within [***] after the minutes have been sent to the members of the Joint IP Committee.

More Definitions of Joint IP Committee

Joint IP Committee or “JIPC”). The JSC may, at its option establish a joint commercialization committee (“Joint Commercialization Committee” or “JCC,” and together with the JDC, JMC and JIPC, the “Joint Subcommittees”). Each Joint Subcommittee shall consist of (i) with respect to the JDC and JMC, at least two (2) representatives from each of the Parties, and (ii) with respect to the JIPC and JCC, at least one (1) representative from each of the Parties, in each case ((i) and (ii)), each with the requisite experience to enable such person to make decisions on behalf of the Parties with respect to the issues falling within the jurisdiction of the relevant Joint Subcommittee; provided, that no Senior Officer may be a representative to a Joint Subcommittee. Simultaneously with establishing each such Joint Subcommittee, the Parties shall identify their initial representatives to such Joint Subcommittee. Each Subcommittee shall have the responsibilities and authority allocated to it in this Section 4.2 and shall operate by the procedures set forth in Section 4.3. If any Joint Subcommittee is not established, then the JSC shall have the responsibilities allocated to such Joint Subcommittee and any reference to such Joint Subcommittee in this Agreement shall be deemed to be a reference to the JSC. No Joint Subcommittee shall have authority that exceeds the authority granted to the JSC.

Joint IP Committee has the meaning set forth in Section 3.1(a)(i).

Joint IP Committee or “JIPC”) to discuss all OptiNose Patents, OptiNose Trademarks and copyright matters relating to the OptiNose IP to the extent licensed to Avanir or its Affiliates for Products and to ensure that Avanir has a reasonable opportunity to review, comment on and cooperate in determining OptiNose’s strategy relating to the filing, prosecution, maintenance and enforcement of the OptiNose Patents.